Surpass is a unique preclinical CRO that understands the current environment in which the medical device/pharma innovator operates. We understand that in order for medtech to continue to attract investment dollars, all stakeholders need to understand the all important value proposition. We do at Surpass and results for our clients are obvious. We are a visible/present/involved member of the innovation continuum. Let me know if you'd like to see how we do things differently at Surpass.